{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T03:29:42Z","timestamp":1767929382593,"version":"3.49.0"},"reference-count":12,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,6,11]],"date-time":"2018-06-11T00:00:00Z","timestamp":1528675200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100004330","name":"GlaxoSmithKline","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004330","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Nephrol"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s12882-018-0925-2","type":"journal-article","created":{"date-parts":[[2018,6,11]],"date-time":"2018-06-11T09:15:23Z","timestamp":1528708523000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Anemia and mortality in patients with nondialysis-dependent chronic kidney disease"],"prefix":"10.1186","volume":"19","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0734-0422","authenticated-orcid":false,"given":"Heide A.","family":"Stirnadel-Farrant","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiacong","family":"Luo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lata","family":"Kler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Borut","family":"Cizman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Delyth","family":"Jones","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Steven M.","family":"Brunelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexander R.","family":"Cobitz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,6,11]]},"reference":[{"issue":"20","key":"925_CR1","doi-asserted-by":"publisher","first-page":"2071","DOI":"10.1056\/NEJMoa062276","volume":"355","author":"TB Drueke","year":"2006","unstructured":"Drueke TB, Locatelli F, Clyne N, Eckardt KU, Macdougall IC, Tsakiris D, Burger HU, Scherhag A. Normalization of hemoglobin level in patients with chronic kidney disease and anemia. N Engl J Med. 2006;355(20):2071\u201384.","journal-title":"N Engl J Med"},{"issue":"20","key":"925_CR2","doi-asserted-by":"publisher","first-page":"2085","DOI":"10.1056\/NEJMoa065485","volume":"355","author":"AK Singh","year":"2006","unstructured":"Singh AK, Szczech L, Tang KL, Barnhart H, Sapp S, Wolfson M, Reddan D. Correction of anemia with epoetin alfa in chronic kidney disease. N Engl J Med. 2006;355(20):2085\u201398.","journal-title":"N Engl J Med"},{"issue":"21","key":"925_CR3","doi-asserted-by":"publisher","first-page":"2019","DOI":"10.1056\/NEJMoa0907845","volume":"361","author":"MA Pfeffer","year":"2009","unstructured":"Pfeffer MA, Burdmann EA, Chen CY, Cooper ME, de Zeeuw D, Eckardt KU, Feyzi JM, Ivanovich P, Kewalramani R, Levey AS, et al. A trial of darbepoetin alfa in type 2 diabetes and chronic kidney disease. N Engl J Med. 2009;361(21):2019\u201332.","journal-title":"N Engl J Med"},{"issue":"5","key":"925_CR4","doi-asserted-by":"publisher","first-page":"1583","DOI":"10.1093\/ndt\/gfq573","volume":"26","author":"D Regidor","year":"2011","unstructured":"Regidor D, McClellan WM, Kewalramani R, Sharma A, Bradbury BD. Changes in erythropoiesis-stimulating agent (ESA) dosing and haemoglobin levels in US non-dialysis chronic kidney disease patients between 2005 and 2009. Nephrol Dial Transplant. 2011;26(5):1583\u201391.","journal-title":"Nephrol Dial Transplant"},{"issue":"6","key":"925_CR5","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1053\/j.ajkd.2013.10.052","volume":"63","author":"AJ Collins","year":"2014","unstructured":"Collins AJ, Monda KL, Molony JT, Li S, Gilbertson DT, Bradbury BD. Effect of facility-level hemoglobin concentration on dialysis patient risk of transfusion. Am J Kidney Dis. 2014;63(6):997\u20131006.","journal-title":"Am J Kidney Dis"},{"issue":"9","key":"925_CR6","doi-asserted-by":"publisher","first-page":"906","DOI":"10.1016\/j.amjmed.2012.03.011","volume":"125","author":"JK Freiburger","year":"2012","unstructured":"Freiburger JK, Ng LJ, Bradbury BD, Kshirsagar AV, Brookhart MA. Changing patterns of anemia management in US hemodialysis patients. Am J Med. 2012;125(9):906\u2013914.e909.","journal-title":"Am J Med"},{"issue":"2","key":"925_CR7","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1053\/j.ajkd.2012.10.002","volume":"61","author":"DS Fuller","year":"2013","unstructured":"Fuller DS, Pisoni RL, Bieber BA, Gillespie BW, Robinson BM. The DOPPS practice monitor for US dialysis care: trends through December 2011. Am J Kidney Dis. 2013;61(2):342\u20136.","journal-title":"Am J Kidney Dis"},{"issue":"1","key":"925_CR8","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1053\/j.ajkd.2012.04.001","volume":"60","author":"RL Pisoni","year":"2012","unstructured":"Pisoni RL, Fuller DS, Bieber BA, Gillespie BW, Robinson BM. The DOPPS practice monitor for US dialysis care: trends through August 2011. Am J Kidney Dis. 2012;60(1):160\u20135.","journal-title":"Am J Kidney Dis"},{"issue":"4\u20135","key":"925_CR9","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1159\/000431335","volume":"41","author":"JB Wetmore","year":"2015","unstructured":"Wetmore JB, Peng Y, Monda KL, Kats AM, Kim DH, Bradbury BD, Collins AJ, Gilbertson DT. Trends in Anemia management practices in patients receiving hemodialysis and peritoneal Dialysis: a retrospective cohort analysis. Am J Nephrol. 2015;41(4\u20135):354\u201361.","journal-title":"Am J Nephrol"},{"issue":"5","key":"925_CR10","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1053\/j.ajkd.2014.05.013","volume":"64","author":"M Thamer","year":"2014","unstructured":"Thamer M, Zhang Y, Kshirsagar O, Cotter DJ, Kaufman JS. Erythropoiesis-stimulating agent use among non-dialysis-dependent CKD patients before and after the trial to Reduce Cardiovascular Events with Aranesp Therapy (TREAT) using a large US health plan database. Am J Kidney Dis. 2014;64(5):706\u201313.","journal-title":"Am J Kidney Dis"},{"issue":"25","key":"925_CR11","doi-asserted-by":"publisher","first-page":"2903","DOI":"10.1161\/CIRCULATIONAHA.111.030411","volume":"124","author":"H Skali","year":"2011","unstructured":"Skali H, Parving H-H, Parfrey PS, Burdmann EA, Lewis EF, Ivanovich P, Keithi-Reddy SR, McGill JB, McMurray JJV, Singh AK, et al. Stroke in patients with type 2 diabetes mellitus, chronic kidney disease, and anemia treated with Darbepoetin Alfa: the trial to reduce cardiovascular events with Aranesp therapy (TREAT) experience. Circulation. 2011;124(25):2903\u20138.","journal-title":"Circulation"},{"issue":"1","key":"925_CR12","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1038\/ki.2013.528","volume":"86","author":"AD Hazzan","year":"2014","unstructured":"Hazzan AD, Shah HH, Hong S, Sakhiya V, Wanchoo R, Fishbane S. Treatment with erythropoiesis-stimulating agents in chronic kidney disease patients with cancer. Kidney Int. 2014;86(1):34\u20139.","journal-title":"Kidney Int"}],"container-title":["BMC Nephrology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-018-0925-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12882-018-0925-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-018-0925-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,10]],"date-time":"2019-06-10T19:10:05Z","timestamp":1560193805000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcnephrol.biomedcentral.com\/articles\/10.1186\/s12882-018-0925-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,6,11]]},"references-count":12,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["925"],"URL":"https:\/\/doi.org\/10.1186\/s12882-018-0925-2","relation":{},"ISSN":["1471-2369"],"issn-type":[{"value":"1471-2369","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,6,11]]},"assertion":[{"value":"30 January 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 May 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 June 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"We used pre-existing, de-identified data. According to 45 CFR part 46 from the United States Department of Health and Human Services this study was exempt from institutional review board approval. We adhered to the Declaration of Helsinki; informed consent was not required. The study was deemed exempt by an Institutional Review Board (Quorum IRB, Seattle, WA).","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"HAS, LK, BC, DJ, and ARC are employees of and own stock in GlaxoSmithKline. JL and SMB are employees of DaVita Clinical Research. SMB\u2019s spouse is an employee of AstraZeneca. This study was sponsored by GlaxoSmithKline.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"135"}}